0001179110-14-012973.txt : 20140815
0001179110-14-012973.hdr.sgml : 20140815
20140815190022
ACCESSION NUMBER: 0001179110-14-012973
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140813
FILED AS OF DATE: 20140815
DATE AS OF CHANGE: 20140815
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: THERAVANCE INC
CENTRAL INDEX KEY: 0001080014
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943265960
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 901 GATEWAY BLVD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 6508086000
MAIL ADDRESS:
STREET 1: 901 GATEWAY BLVD
CITY: S. SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: ADVANCED MEDICINE INC
DATE OF NAME CHANGE: 20000302
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LEE JUNNING
CENTRAL INDEX KEY: 0001596187
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30319
FILM NUMBER: 141047689
MAIL ADDRESS:
STREET 1: 901 GATEWAY BLVD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
edgar.xml
FORM 4 -
X0306
4
2014-08-13
0
0001080014
THERAVANCE INC
THRX
0001596187
LEE JUNNING
THERAVANCE, INC.
951 GATEWAY BLVD.
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Sr. VP, Technical Operations
Common Stock
2014-08-13
4
M
0
13882
9.81
A
258324
D
Common Stock
2014-08-13
4
M
0
12516
14.53
A
270840
D
Common Stock
2014-08-13
4
M
0
24338
12.66
A
295178
D
Common Stock
2014-08-13
4
M
0
23705
12.66
A
318883
D
Common Stock
2014-08-13
4
S
0
53424
22.50
D
265459
D
Stock Option (Right to Buy)
9.81
2014-08-13
4
M
0
13882
0
D
2014-09-03
Common Stock
13882
0
D
Stock Option (Right to Buy)
14.53
2014-08-13
4
M
0
12516
0
D
2015-02-09
Common Stock
12516
0
D
Stock Option (Right to Buy)
12.66
2014-08-13
4
M
0
24338
0
D
2014-10-03
Common Stock
24338
0
D
Stock Option (Right to Buy)
12.66
2014-08-13
4
M
0
23705
0
D
2014-10-03
Common Stock
23705
0
D
This transaction was executed in multiple trades at prices from $22.49 to $22.53. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or the security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
Exercisable immediately.
Junning Lee
2014-08-15